Paper9711908
Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.
Escribano L and 4 others. Leuk Lymphoma, 1998. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Papers, record 9711908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9711908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematologic Neoplasms | Major topic |
| Hematopoiesis | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Proto-Oncogene Proteins c-kit | Major topic |
| Acute Disease | |
| Animals | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Leukemia | |
| Mast Cells | |
| Paraproteinemias |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02431403 | ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma | Background |
Source ClinicalTrials.gov
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42826002 | Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms. | Blood Res | 2026 | https://conductscience.org/library/papers/42826002 | PubMed |
| 42557300 | Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42557300 | PubMed |
| 42001795 | Characterizing the impact of MLL fusion variants and fusion partners on leukemia plasticity using a human CRISPR-engineered MLL-rearranged leukemia model. | Neoplasia | 2026 | https://conductscience.org/library/papers/42001795 | PubMed |
| 41500957 | Re-expression of embryonic stem cell markers in malignant tissue: an observational study in pancreatic cancer. | Anat Cell Biol | 2026 | https://conductscience.org/library/papers/41500957 | PubMed |
| 40407685 | Dynamic Changes of Immunoreactive CD34, CD117, and CD41 Hematopoietic Stem Cells in Human Placentas of Different Gestational Ages. | J Dev Biol | 2025 | https://conductscience.org/library/papers/40407685 | PubMed |
| 40181544 | CAR-T cell therapy for treatment of acute myeloid leukemia, advances and outcomes. | Mol Ther | 2025 | https://conductscience.org/library/papers/40181544 | PubMed |
| 40179083 | Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study. | PLoS One | 2025 | https://conductscience.org/library/papers/40179083 | PubMed |
| 39778871 | An immunohistochemical study of thanatophoric dysplasia type 1 after fetus autopsy examination. | Congenit Anom (Kyoto) | 2025 | https://conductscience.org/library/papers/39778871 | PubMed |
| 38177056 | Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies. | Hematol Transfus Cell Ther | 2024 | https://conductscience.org/library/papers/38177056 | PubMed |
| 37583386 | Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells. | Mol Ther Oncolytics | 2023 | https://conductscience.org/library/papers/37583386 | PubMed |
| 37330575 | Biomarkers as targets for CAR-T/NK cell therapy in AML. | Biomark Res | 2023 | https://conductscience.org/library/papers/37330575 | PubMed |
| 36245718 | Diagnostic challenges in acute monoblastic/monocytic leukemia in children. | Front Pediatr | 2022 | https://conductscience.org/library/papers/36245718 | PubMed |
| 36103274 | Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia. | ACS Biomater Sci Eng | 2022 | https://conductscience.org/library/papers/36103274 | PubMed |
| 35975202 | Intra-ovarian injection of bone marrow-derived c-Kit+ cells for ovarian rejuvenation in menopausal rats. | Bioimpacts | 2022 | https://conductscience.org/library/papers/35975202 | PubMed |
| 35886877 | Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35886877 | PubMed |
| 35862720 | Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis. | Infect Immun | 2022 | https://conductscience.org/library/papers/35862720 | PubMed |
| 33953290 | T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. | Leukemia | 2021 | https://conductscience.org/library/papers/33953290 | PubMed |
| 33878141 | Human hematopoietic microenvironments. | PLoS One | 2021 | https://conductscience.org/library/papers/33878141 | PubMed |
| 33469673 | Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressing gastric cancer model. | Int J Oncol | 2021 | https://conductscience.org/library/papers/33469673 | PubMed |
| 32766988 | Identification and Immunophenotypic Characterization of Normal and Pathological Mast Cells. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/32766988 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| KIT | 3815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| NCAM1 | 4684 | PubTator's text mining | https://conductscience.org/library/genes/4684 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9711908
GET https://conductscience.org/api/papers/v1/9711908/cited_by?page=2